GW Pharmaceuticals PLC (NASDAQ: GWPH)has a lot going right at the moment. Its cannabis-derived epilepsy tincture is one of the most highly anticipated potential drug launches this year. Epidiolex scored high marks in pivotal trials underpinning an application under review at the moment, and many analysts are predicting a blockbuster drug launchlater this year.
Investors Are Betting Big Against This Marijuana Stock — Are They Wrong?
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться